Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 1855 word(s) 1855 2021-08-10 11:35:40 |
2 format correct Meta information modification 1855 2021-08-24 08:42:22 |

Video Upload Options

We provide professional Video Production Services to translate complex research into visually appealing presentations. Would you like to try it?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Noda, T. Quercetin Induse Aggrephagy. Encyclopedia. Available online: https://encyclopedia.pub/entry/13490 (accessed on 18 November 2024).
Noda T. Quercetin Induse Aggrephagy. Encyclopedia. Available at: https://encyclopedia.pub/entry/13490. Accessed November 18, 2024.
Noda, Takeshi. "Quercetin Induse Aggrephagy" Encyclopedia, https://encyclopedia.pub/entry/13490 (accessed November 18, 2024).
Noda, T. (2021, August 24). Quercetin Induse Aggrephagy. In Encyclopedia. https://encyclopedia.pub/entry/13490
Noda, Takeshi. "Quercetin Induse Aggrephagy." Encyclopedia. Web. 24 August, 2021.
Quercetin Induse Aggrephagy
Edit

Tartary buckwheat is used as an ingredient in flour and tea, as well as in traditional Chinese medicine for its antioxidant effects. Here, we found that an ethanol extract of tartary buckwheat (TBE) potently induced autophagy flux in HeLa cells by suppressing mTORC1 activity, as revealed by dephosphorylation of the mTORC1 substrates Ulk1, S6K, and 4EBP, as well as by the nuclear translocation of transcriptional factor EB. In addition to non-selective bulk autophagy, TBE also induced aggrephagy, which is defined as autophagy against aggregated proteins. Quercetin is a flavonol found at high levels in TBE. 

tartary buckwheat mTORC1 aggrephagy autophagy quercetin

1. Introduction

Macroautophagy (hereafter referred to simply as autophagy) is an intracellular degradation process that supports cellular homeostasis [1]. The mechanisms that underlie autophagy were initially characterized in yeast studies, but are now understood in mammals as well [2]. As a result, increasing numbers of studies have demonstrated the vital connection between autophagy and a wide variety of human diseases, such as cancer and neurodegenerative diseases [3]. To address these autophagy-related conditions, a number of attempts by the pharmaceutical industry and academia are underway worldwide to artificially regulate autophagy activity in vivo by the use of exogenous compounds [4]. In particular, traditional Chinese medicine has attracted wide attention as a source of potential autophagy modulators [5]. This therapeutic approach has a different foundation than European medicine, and it is broadly accepted, mainly in East Asia. It is based on a long history of prescription and experience, and therefore while its physiological effects are assured to some degree, the underlying molecular mechanisms are largely undetermined. We recently reported that Shigyakusan, a mixture of compounds used in Kampo (Japanese-style traditional Chinese medicine) and a close relative of Shini-san in traditional Chinese medicine, has a suppressive effect on autophagy [6].
Tartary buckwheat (Fagopyrum tataricum) is a species of herbaceous plant whose grain is used to prepare flour, noodles, and herbal tea, all mainly in Central and East Asia [7]. Compared to common buckwheat (Fagopyrum esculentum), it has a characteristically bitter flavor. In addition to its use in food, the ethanol extract of tartary buckwheat (TBE) is utilized as a component of traditional Chinese medicine [8]. The administration of TBE to mouse brain and liver was shown to reduce antioxidant enzyme levels [8]. It also exerted an antibacterial effect against Propionibacterium and Staphylococci species [9]. We conducted a pilot survey to determine whether any of the ingredients of Maopu buckwheat liquor, a Chinese liquor containing various Chinese herbal medicine extracts, affected autophagy activity, and found that TBE strongly induced autophagy. Therefore, we performed the present study to elucidate the molecular mechanisms of this property of TBE and its effect on hepatocytes.

2. TBE Enhances Dephosphorylation of mTORC1 Substrates

To investigate how TBE induced autophagy, we focused on the protein kinase mTORC1, which negatively regulates autophagy induction by alternating the phosphorylation level of proteins involved in the autophagy regulation process [10]. Transcriptional factor EB (TFEB) is a mTORC1 kinase substrate and an important regulator of autophagy/lysosome protein biogenesis [11]. Under nutrient-rich conditions, active mTORC1 phosphorylated TFEB and retained TFEB in the cytoplasm, whereas dephosphorylated TFEB under starvation conditions translocated into the nucleus. However, when the cells were treated with TBE, GFP-TFEB was localized in the nucleus even under nutrient-rich conditions (Figure 1A,B).
Figure 1. TBE enhances dephosphorylation of mTORC1 substrates. (A) GFP-TFEB-expressing HeLa cells were treated with or without Torin-1 or TBE for 4 h and observed under a confocal microscope. Bar: 25 µm. (B) The graph shows the ratio of GFP intensity in a 7 µm2 of the cytosol to the sum of GFP intensities in certain areas of the cytoplasm and nucleus. Median: line; upper and lower quartiles: boxes; 1.5 interquartile range: whiskers. * denotes p < 0.05 by unpaired two-tailed Student’s t-test. (C) HeLa cells were treated with or without Torin-1 or TBE for 4 h and subjected to Western blotting using anti-phospho-ULK1 (Ser757), anti-ULK, anti-TFEB, anti-phospho-S6K, anti-p70 kinase, anti-4E-BP1, and anti-tubulin antibodies. The graph shows the quantification of each band intensity.
We next examined the phosphorylation levels of mTORC1 substrates by Western blotting. The band size of TFEB was shifted down in response to Torin-1, indicating that TFEB was dephosphorylated (Figure 1C). TFEB was also shifted when the cells were treated with TBE (Figure 1C).
ULK1 protein kinase was another mTORC1 kinase substrate. The serine-757 site of ULK1 was phosphorylated by active mTORC1 to suppress autophagy, while treatment with the mTORC1 inhibitor Torin-1 led to ULK1 dephosphorylation at this serine site [12]. TBE treatment also resulted in dephosphorylation of this site (Figure 1C). The other major mTORC1 substrates, the ribosomal protein S6 kinase (S6K) and the translation initiation factor 4E-binding protein (4E-BP) [13], were also dephosphorylated in the presence of TBE (Figure 1C). Collectively, these results show that TBE suppresses mTORC1 kinase activity.

3. TBE Induces Autophagy against Protein Aggregation

In addition to bulk autophagy, which degrades nonselective cytosolic components, a wide range of specific targets are also subjected to autophagy; in this case, the process is known as selective autophagy [14]. Among these targets are aggregated proteins which are engulfed by autophagosomes and eventually degraded by a process called aggrephagy, one form of selective autophagy. In a previous study, protein aggregates were artificially induced by halting translation with puromycin treatment [15]. P62/SQSTM-1, an autophagy-related adaptor protein, is localized with protein aggregations and can be utilized as a protein aggregation marker [16]. In this study, p62-positive punctae formed after treatment with puromycin for 4 h, representing protein aggregates (Figure 2). Eighteen hours after puromycin was washed out, most p62-positive punctae disappeared, although these punctae persisted in autophagy-defective HeLa cells [15] [Ikari et al., manuscript in preparation], indicating that their removal was dependent on aggrephagy. Torin-1 treatment accelerated this process and resulted in a reduced number of p62-positive punctae, but the effect was moderate after just a 1-h washout (Figure 2). However, TBE treatment enhanced the clearance of p62 punctae even within 1 hr (Figure 2), indicating that TBE induces aggrephagy.
Figure 2. TBE and quercetin enhance the induction of aggrephagy. HeLa cells were treated with puromycin for 4 h, Figure 1. Bafilomycin A1, TBE, quercetin, or rutin at the indicated concentrations for 1 h. p62 was detected by immunostaining. The graph shows the number of p62 dots over 1.4 µm in diameter per HeLa cell. Bar: 25 µm. Median: line; upper and lower quartiles: boxes; 1.5 interquartile range: whiskers. * denotes p < 0.05 by unpaired two-tailed Student’s t-test.

4. Quercetin Is Responsible for the TBE Effect on Autophagy Induction

Rutin is a flavonoid that occurs at much higher concentrations in tartary buckwheat than in common buckwheat. We examined whether rutin could induce autophagy, but it did not do so even at a high concentration (Figure 2). Rutin consists of the flavonol quercetin and the disaccharide rutinose. A previous report showed that TBE includes a highly active rutin-degrading enzym, and, as a result, rutin is promptly degraded into quercetin in aqueous extraction [17][18]. We therefore examined whether quercetin affected autophagy. The TBE batch used in this study comprised 2.8% (w/w) of quercetin according to HPLC analysis (data not shown), which is equivalent to 130 µM in 1500 µg/mL of TBE. We treated HeLa cells to determine how aggrephagy was affected by a series of quercetin concentrations. Aggrephagy was promoted by 100 µM of quercetin, but not by 25 or 50 µM (Figure 2). We further examined the effects of quercetin on autophagy using GFP-LC3-expressing HeLa cells. When quercetin was added, the number of GFP-LC3 punctae was higher compared to vehicle control (Figure 3A). We also examined the effect of quercetin treatment on mTORC1 activity. When HeLa cells expressing GFP-TFEB were treated with quercetin, GFP-TFEB showed nuclear translocation similar to that seen following treatment with Torin-1 or TBE (Figure 3B).
Figure 3. Quercetin enhances autophagy. (A) GFP-LC3-expressing HeLa cells were treated with or without Torin-1, TBE, or quercetin for 4 h under nutrient-rich conditions. The graph shows the number of GFP-LC3 punctae over 1.3 µm in diameter per cell. (B) GFP-TFEB-expressing HeLa cells were treated with or without Torin-1, TBE, or quercetin for 4 h under nutrient-rich conditions. The graph shows the ratio of GFP intensity in a certain area of the cytosol to the sum of GFP intensities in certain areas of the cytoplasm and nucleus. (C) Huh7 cells were treated with puromycin for 4 h, and further cultured with or without Torin-1, TBE, or quercetin for 1 h after washing out puromycin. Intracellular p62 was detected by immunostaining. The graph shows the number of p62 dots over 2.5 µm in diameter per cell. Median: line; upper and lower quartiles: boxes; 1.5 interquartile range: whiskers. Bar: 10 µm for (A,B); 25 µm for (C). * denotes p < 0.05 by unpaired two-tailed Student’s t-test.

5. Discussion

In this study, we showed that TBE treatment induced autophagy by suppressing mTORC1 activity, and that quercetin was the ingredient that exerted this effect. We further revealed that TBE and quercetin promoted not only bulk autophagy, but also aggrephagy against aggregated proteins.
The initial phase of this project investigated the effects on autophagy of five ingredients in Maopu buckwheat liquor, and we eventually succeeded in identifying quercetin as the ingredient with potent aggrephagy-inducing ability. It remains possible that compounds in TBE other than quercetin also contribute to this effect. However, quercetin may be the primary ingredient capable of inducing autophagy on its own. Previous studies have reported that quercetin is associated with autophagy in several contexts. First, quercetin treatment induced autophagy in gastric cancer cells, causing a pronounced pro-apoptotic effect [19]. Subsequently, Klappan et al. reported that quercetin possesses a proteasome inhibitory effect that leads to mTORC1 inhibition [20]. However, in contrast with our findings, their study reported that quercetin treatment induced protein aggregation, mostly inside the nucleus [20]. Induction of autophagy by quercetin has been observed in several tissues and diseases, including diabetic nephropathy [21], oocytes from aged mice [22], intervertebral disc degeneration [23], myelodysplastic bone marrow [24], and human retinal pigment epithelial cells [25], while one study reported that quercetin attenuated autophagy in a rat model of traumatic brain injury [26]. Regardless of these previous studies, here we performed a comprehensive set of autophagy assays that unquestionably proved the effect of quercetin on autophagy for the first time [27]. As suggested by our study and the aforementioned reports, these effects could be mediated by mTORC1 suppression. The underlying molecular mechanism is still to be determined, but a recent report that quercetin directly binds to mTORC1 has interesting implications [28].
Both TBE and quercetin induce bulk autophagy and aggrephagy. TBE and quercetin are less effective at suppressing mTORC1 than Troin-1. Nevertheless, TBE and quercetin induce aggrephagy at an even earlier time (1 hr) than the point at which Torin-1 exerted its limited effect on aggrephagy. Therefore, we speculate that a pathway other than that involving mTORC1 is affected by quercetin in aggrephagy, although the identity of this additional pathway is still to be determined. In the liver, the pathogenesis of alcoholic hepatitis is closely linked to the accumulation of protein aggregates called Mallory–Denk bodies [29], and the clearance of these aggregates could potentially alleviate hepatitis. In addition, protein aggregates in the liver provoke tumorigenesis [30], and aggrephagy is capable of clearing these proteins [31]. Quercetin is linked to alcohol-induced liver injury because it enhances autophagy against mitochondria (mitophagy) [32] and lipid droplets (lipophagy) [33]. Combined with these effects, the ability of TBE to enhance aggrephagy could potentially prevent these diseases. Future research to clarify this possibility is needed, especially using animal models.

References

  1. Mizushima, N.; Yoshimori, T.; Ohsumi, Y. The Role of Atg Proteins in Autophagosome Formation. Annu. Rev. Cell Dev. Biol. 2011, 27, 107–132.
  2. Nakatogawa, H. Mechanisms Governing Autophagosome Biogenesis. Nat. Rev. Mol. Cell Biol. 2020, 21, 439–458.
  3. Thorburn, A. Autophagy and Disease. J. Biol. Chem. 2018, 293, 5425–5430.
  4. Fleming, A.; Noda, T.; Yoshimori, T.; Rubinsztein, D.C. Chemical Modulators of Autophagy as Biological Probes and Potential Therapeutics. Nat. Chem. Biol. 2011, 7, 9–17.
  5. Wang, S.-F.; Wu, M.-Y.; Cai, C.-Z.; Li, M.; Lu, J.-H. Autophagy Modulators from Traditional Chinese Medicine: Mechanisms and Therapeutic Potentials for Cancer and Neurodegenerative Diseases. J. Ethnopharmacol. 2016, 194, 861–876.
  6. Ikari, S.; Lu, S.-L.; Hao, F.; Imai, K.; Araki, Y.; Yamamoto, Y.; Tsai, C.-Y.; Nishiyama, Y.; Shitan, N.; Yoshimori, T.; et al. Starvation-Induced Autophagy via Calcium-Dependent TFEB Dephosphorylation Is Suppressed by Shigyakusan. PLoS ONE 2020, 15, e0230156.
  7. Jin, H.-M.; Wei, P. Anti-Fatigue Properties of Tartary Buckwheat Extracts in Mice. Int. J. Mol. Sci. 2011, 12, 4770–4780.
  8. Sadauskiene, I.; Liekis, A.; Bernotiene, R.; Sulinskiene, J.; Kasauskas, A.; Zekonis, G. The Effects of Buckwheat Leaf and Flower Extracts on Antioxidant Status in Mouse Organs. Oxidative Med. Cell. Longev. 2018, 2018, 1–7.
  9. Wang, L.; Yang, X.; Qin, P.; Shan, F.; Ren, G. Flavonoid Composition, Antibacterial and Antioxidant Properties of Tartary Buckwheat Bran Extract. Ind. Crop. Prod. 2013, 49, 312–317.
  10. Noda, T. Regulation of Autophagy through TORC1 and MTORC1. Biomolecules 2017, 7, 52.
  11. Settembre, C.; Di Malta, C.; Polito, V.A.; Arencibia, M.G.; Vetrini, F.; Erdin, S.; Erdin, S.U.; Huynh, T.; Medina, D.; Colella, P.; et al. TFEB Links Autophagy to Lysosomal Biogenesis. Science 2011, 332, 1429–1433.
  12. Kim, J.; Kundu, M.; Viollet, B.; Guan, K.-L. AMPK and MTOR Regulate Autophagy through Direct Phosphorylation of Ulk1. Nat. Cell Biol. 2011, 13, 132–141.
  13. Fingar, D.C.; Richardson, C.J.; Tee, A.R.; Cheatham, L.; Tsou, C.; Blenis, J. MTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4E. MCB 2004, 24, 200–216.
  14. Zaffagnini, G.; Martens, S. Mechanisms of Selective Autophagy. J. Mol. Biol. 2016, 428, 1714–1724.
  15. Kirkin, V.; Lamark, T.; Sou, Y.-S.; Bjørkøy, G.; Nunn, J.L.; Bruun, J.-A.; Shvets, E.; McEwan, D.G.; Clausen, T.H.; Wild, P.; et al. A Role for NBR1 in Autophagosomal Degradation of Ubiquitinated Substrates. Mol. Cell 2009, 33, 505–516.
  16. Komatsu, M.; Waguri, S.; Koike, M.; Sou, Y.; Ueno, T.; Hara, T.; Mizushima, N.; Iwata, J.; Ezaki, J.; Murata, S.; et al. Homeostatic Levels of P62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice. Cell 2007, 131, 1149–1163.
  17. Yasuda, T.; Masaki, K.; Kashiwagi, T. An Enzyme Degrading Rutin in Tartary Buckwheat Seeds. Nippon Shokuhin Kogyo Gakkaishi 1992, 39, 994–1000.
  18. Zhang, Y.; Li, J.; Yuan, Y.; Gu, J.; Chen, P. Purification, characterization and partial primary structure analysis of rutin-degrading enzyme in tartary buckwheat seeds. Sheng Wu Gong Cheng Xue Bao 2017, 33, 796–807.
  19. Wang, K.; Liu, R.; Li, J.; Mao, J.; Lei, Y.; Wu, J.; Zeng, J.; Zhang, T.; Wu, H.; Chen, L.; et al. Quercetin Induces Protective Autophagy in Gastric Cancer Cells: Involvement of Akt-MTOR- and Hypoxia-Induced Factor 1α-Mediated Signaling. Autophagy 2011, 7, 966–978.
  20. Klappan, A.K.; Hones, S.; Mylonas, I.; Brüning, A. Proteasome Inhibition by Quercetin Triggers Macroautophagy and Blocks MTOR Activity. Histochem. Cell Biol. 2012, 137, 25–36.
  21. Lu, Q.; Ji, X.-J.; Zhou, Y.-X.; Yao, X.-Q.; Liu, Y.-Q.; Zhang, F.; Yin, X.-X. Quercetin Inhibits the MTORC1/P70S6K Signaling-Mediated Renal Tubular Epithelial–Mesenchymal Transition and Renal Fibrosis in Diabetic Nephropathy. Pharmacol. Res. 2015, 99, 237–247.
  22. Cao, Y.; Zhao, H.; Wang, Z.; Zhang, C.; Bian, Y.; Liu, X.; Zhang, C.; Zhang, X.; Zhao, Y. Quercetin Promotes in Vitro Maturation of Oocytes from Humans and Aged Mice. Cell Death Dis. 2020, 11, 965.
  23. Wang, D.; He, X.; Wang, D.; Peng, P.; Xu, X.; Gao, B.; Zheng, C.; Wang, H.; Jia, H.; Shang, Q.; et al. Quercetin Suppresses Apoptosis and Attenuates Intervertebral Disc Degeneration via the SIRT1-Autophagy Pathway. Front. Cell Dev. Biol. 2020, 8, 613006.
  24. Daw, S.; Law, S. Quercetin Induces Autophagy in Myelodysplastic Bone Marrow Including Hematopoietic Stem/Progenitor Compartment. Environ. Toxicol. 2021, 36, 149–167.
  25. Li, D.L.; Mao, L.; Gu, Q.; Wei, F.; Gong, Y.-Y. Quercetin Protects Retina External Barrier from Oxidative Stress Injury by Promoting Autophagy. Cutan. Ocul. Toxicol. 2021, 40, 7–13.
  26. Du, G.; Zhao, Z.; Chen, Y.; Li, Z.; Tian, Y.; Liu, Z.; Liu, B.; Song, J. Quercetin Attenuates Neuronal Autophagy and Apoptosis in Rat Traumatic Brain Injury Model via Activation of PI3K/Akt Signaling Pathway. Neurol. Res. 2016, 38, 1012–1019.
  27. Klionsky, D.J.; Abdel-Aziz, A.K.; Abdelfatah, S.; Abdellatif, M.; Abdoli, A.; Abel, S.; Abeliovich, H.; Abildgaard, M.H.; Abudu, Y.P.; Acevedo-Arozena, A.; et al. Guidelines for the Use and Interpretation of Assays for Monitoring Autophagy (4th Edition). Autophagy 2021, 17, 1–382.
  28. Huang, Y.; Chen, Y.; Shaw, A.M.; Goldfine, H.; Tian, J.; Cai, J. Enhancing TFEB-Mediated Cellular Degradation Pathways by the MTORC1 Inhibitor Quercetin. Oxidative Med. Cell. Longev. 2018, 2018, 1–9.
  29. French, S.; Masouminia, M.; Samadzadeh, S.; Tillman, B.; Mendoza, A.; French, B. Role of Protein Quality Control Failure in Alcoholic Hepatitis Pathogenesis. Biomolecules 2017, 7, 11.
  30. Takamura, A.; Komatsu, M.; Hara, T.; Sakamoto, A.; Kishi, C.; Waguri, S.; Eishi, Y.; Hino, O.; Tanaka, K.; Mizushima, N. Autophagy-Deficient Mice Develop Multiple Liver Tumors. Genes Dev. 2011, 25, 795–800.
  31. Komatsu, M.; Waguri, S.; Ueno, T.; Iwata, J.; Murata, S.; Tanida, I.; Ezaki, J.; Mizushima, N.; Ohsumi, Y.; Uchiyama, Y.; et al. Impairment of Starvation-Induced and Constitutive Autophagy in Atg7-Deficient Mice. J. Cell Biol. 2005, 169, 425–434.
  32. Yu, X.; Xu, Y.; Zhang, S.; Sun, J.; Liu, P.; Xiao, L.; Tang, Y.; Liu, L.; Yao, P. Quercetin Attenuates Chronic Ethanol-Induced Hepatic Mitochondrial Damage through Enhanced Mitophagy. Nutrients 2016, 8, 27.
  33. Zeng, H.; Guo, X.; Zhou, F.; Xiao, L.; Liu, J.; Jiang, C.; Xing, M.; Yao, P. Quercetin Alleviates Ethanol-Induced Liver Steatosis Associated with Improvement of Lipophagy. Food Chem. Toxicol. 2019, 125, 21–28.
More
Information
Subjects: Biology
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 452
Revisions: 2 times (View History)
Update Date: 24 Aug 2021
1000/1000
ScholarVision Creations